Emerging trends in clinical implications of bio-conjugated silver nanoparticles in drug delivery

Publication date: March 2020Source: Colloid and Interface Science Communications, Volume 35Author(s): Parteek Prasher, Mousmee Sharma, Harish Mudila, Gaurav Gupta, Abhishek Kumar Sharma, Deepak Kumar, Hamid A. Bakshi, Poonam Negi, Deepak N. Kapoor, Dinesh Kumar Chellappan, Murtaza M. Tambuwala, Kamal DuaAbstractFrom nanopharmaceutics to renewable energy, silver nanoparticles (AgNPs) present innumerable applications in the contemporary era. However, the associated toxicity to the biosystems limits their application. Effective utilization of AgNPs, therefore, requires their surface conjugation with biologically benevolent moieties that enhance the bio-acceptability of silver-based nanosystems, and supplementary functionalities for further extension of their unique applications. The clinical importance of AgNPs was established long ago, but their clinical utilization has been explored only recently with the phenomenon of bio-conjugation. The biomolecule-conjugated AgNPs present operable solutions for tedious clinical complications of the present era, such as multidrug resistance, designing of pharmaceuticals with improved bioavailability, superior drug delivery vehicles and in situ bio imaging of important metabolites that utilize the biomolecule-anchored surface engineered AgNPs. This review epigrammatically discusses some interesting clinical applications of surface conjugated AgNPs with biomolecules such as peptides, nucleic acids, amino acids and antibodies in the current na...
Source: Colloids and Interface Science Communications - Category: Nanotechnology Source Type: research